Published in Cell Rep on December 07, 2012
Reprogramming committed murine blood cells to induced hematopoietic stem cells with defined factors. Cell (2014) 2.44
Wnt signaling controls the specification of definitive and primitive hematopoiesis from human pluripotent stem cells. Nat Biotechnol (2014) 2.05
Induction of multipotential hematopoietic progenitors from human pluripotent stem cells via respecification of lineage-restricted precursors. Cell Stem Cell (2013) 1.68
Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy. Nat Biotechnol (2013) 1.39
Early dynamic fate changes in haemogenic endothelium characterized at the single-cell level. Nat Commun (2013) 1.35
Scalable generation of universal platelets from human induced pluripotent stem cells. Stem Cell Reports (2014) 1.25
Signalling pathways that control vertebrate haematopoietic stem cell specification. Nat Rev Immunol (2013) 1.21
Human definitive haemogenic endothelium and arterial vascular endothelium represent distinct lineages. Nat Cell Biol (2015) 1.16
Hematopoietic specification from human pluripotent stem cells: current advances and challenges toward de novo generation of hematopoietic stem cells. Blood (2013) 1.14
Defining the path to hematopoietic stem cells. Nat Biotechnol (2013) 1.11
Flow-induced protein kinase A-CREB pathway acts via BMP signaling to promote HSC emergence. J Exp Med (2015) 1.07
A short history of hemogenic endothelium. Blood Cells Mol Dis (2013) 1.05
Functional analysis of a chromosomal deletion associated with myelodysplastic syndromes using isogenic human induced pluripotent stem cells. Nat Biotechnol (2015) 1.04
Tenascin C promotes hematoendothelial development and T lymphoid commitment from human pluripotent stem cells in chemically defined conditions. Stem Cell Reports (2014) 0.99
De novo generation of HSCs from somatic and pluripotent stem cell sources. Blood (2015) 0.94
New cell sources for T cell engineering and adoptive immunotherapy. Cell Stem Cell (2015) 0.93
Deciphering the hierarchy of angiohematopoietic progenitors from human pluripotent stem cells. Cell Cycle (2013) 0.92
Large-scale hematopoietic differentiation of human induced pluripotent stem cells provides granulocytes or macrophages for cell replacement therapies. Stem Cell Reports (2015) 0.89
Lost in translation: pluripotent stem cell-derived hematopoiesis. EMBO Mol Med (2015) 0.88
Inhibition of β-catenin signaling respecifies anterior-like endothelium into beating human cardiomyocytes. Development (2015) 0.88
An activin receptor IIA ligand trap promotes erythropoiesis resulting in a rapid induction of red blood cells and haemoglobin. Br J Haematol (2014) 0.87
Reprogramming antitumor immunity. Trends Immunol (2014) 0.86
Targeting innate immunity for neurodegenerative disorders of the central nervous system. J Neurochem (2016) 0.85
Targeted Application of Human Genetic Variation Can Improve Red Blood Cell Production from Stem Cells. Cell Stem Cell (2015) 0.85
Expression of chimeric receptor CD4ζ by natural killer cells derived from human pluripotent stem cells improves in vitro activity but does not enhance suppression of HIV infection in vivo. Stem Cells (2014) 0.85
Cell signaling pathways involved in hematopoietic stem cell specification. Exp Cell Res (2014) 0.84
Generating human hematopoietic stem cells in vitro -exploring endothelial to hematopoietic transition as a portal for stemness acquisition. FEBS Lett (2016) 0.84
EXTL3 mutations cause skeletal dysplasia, immune deficiency, and developmental delay. J Exp Med (2017) 0.84
In vitro human embryonic stem cell hematopoiesis mimics MYB-independent yolk sac hematopoiesis. Haematologica (2014) 0.83
Biomechanical force in blood development: extrinsic physical cues drive pro-hematopoietic signaling. Differentiation (2013) 0.83
Haematopoietic stem and progenitor cells from human pluripotent stem cells. Nature (2017) 0.82
Hematopoietic stem cell expansion and generation: the ways to make a breakthrough. Blood Res (2015) 0.82
The balance of positive and negative effects of TGF-β signaling regulates the development of hematopoietic and endothelial progenitors in human pluripotent stem cells. Stem Cells Dev (2013) 0.82
T Cell Genesis: In Vitro Veritas Est? Trends Immunol (2016) 0.82
Broad T-cell receptor repertoire in T-lymphocytes derived from human induced pluripotent stem cells. PLoS One (2014) 0.81
Pleiotropic roles of Notch signaling in normal, malignant, and developmental hematopoiesis in the human. EMBO Rep (2014) 0.81
Transcription factor-mediated reprogramming toward hematopoietic stem cells. EMBO J (2015) 0.81
Medial HOXA genes demarcate haematopoietic stem cell fate during human development. Nat Cell Biol (2016) 0.81
Progress towards generation of human haematopoietic stem cells. Nat Cell Biol (2016) 0.81
GSK3β Inhibition Promotes Efficient Myeloid and Lymphoid Hematopoiesis from Non-human Primate-Induced Pluripotent Stem Cells. Stem Cell Reports (2016) 0.81
In vivo repopulating activity emerges at the onset of hematopoietic specification during embryonic stem cell differentiation. Stem Cell Reports (2015) 0.80
Inducing definitive hematopoiesis in a dish. Nat Biotechnol (2014) 0.80
Progress and obstacles towards generating hematopoietic stem cells from pluripotent stem cells. Curr Opin Hematol (2015) 0.80
A view of human haematopoietic development from the Petri dish. Nat Rev Mol Cell Biol (2016) 0.80
Understanding platelet generation from megakaryocytes: implications for in vitro-derived platelets. Blood (2016) 0.79
New markers for tracking endoderm induction and hepatocyte differentiation from human pluripotent stem cells. Development (2015) 0.79
High-Efficiency Serum-Free Feeder-Free Erythroid Differentiation of Human Pluripotent Stem Cells Using Small Molecules. Stem Cells Transl Med (2016) 0.79
The RUNX1 +24 enhancer and P1 promoter identify a unique subpopulation of hematopoietic progenitor cells derived from human pluripotent stem cells. Stem Cells (2015) 0.79
Novel Genome-Editing Tools to Model and Correct Primary Immunodeficiencies. Front Immunol (2015) 0.79
Retinoic acid regulates hematopoietic development from human pluripotent stem cells. Stem Cell Reports (2015) 0.79
In Vitro T-Cell Generation From Adult, Embryonic, and Induced Pluripotent Stem Cells: Many Roads to One Destination. Stem Cells (2015) 0.78
GATA2(-/-) human ESCs undergo attenuated endothelial to hematopoietic transition and thereafter granulocyte commitment. Cell Regen (Lond) (2015) 0.78
Rescue of DNA-PK Signaling and T-Cell Differentiation by Targeted Genome Editing in a prkdc Deficient iPSC Disease Model. PLoS Genet (2015) 0.77
Generation of X-CGD cells for vector evaluation from healthy donor CD34(+) HSCs by shRNA-mediated knock down of gp91(phox). Mol Ther Methods Clin Dev (2014) 0.77
Modeling altered T-cell development with induced pluripotent stem cells from patients with RAG1-dependent immune deficiencies. Blood (2016) 0.77
A synthetic three-dimensional niche system facilitates generation of functional hematopoietic cells from human-induced pluripotent stem cells. J Hematol Oncol (2016) 0.76
Wading through the waves of human embryonic hemogenesis. Cell Cycle (2013) 0.76
Engineering Hematopoietic Stem Cells: Lessons from Development. Cell Stem Cell (2016) 0.76
Development of hematopoietic stem and progenitor cells from human pluripotent stem cells. J Cell Biochem (2015) 0.76
Bottlenecks in deriving definitive hematopoietic stem cells from human pluripotent stem cells: a CIRM mini-symposium and workshop report. Stem Cells Transl Med (2014) 0.76
CRISPR/Cas9 Targeted Gene Editing and Cellular Engineering in Fanconi Anemia. Stem Cells Dev (2016) 0.76
CRISPR/Cas9-based genetic correction for recessive dystrophic epidermolysis bullosa. NPJ Regen Med (2016) 0.75
Development of autologous blood cell therapies. Exp Hematol (2016) 0.75
Modeling Human Bone Marrow Failure Syndromes Using Pluripotent Stem Cells and Genome Engineering. Mol Ther (2015) 0.75
Silent IL2RG Gene Editing in Human Pluripotent Stem Cells. Mol Ther (2015) 0.75
Chimeric Antigen Receptors: A Cell and Gene Therapy Perspective. Mol Ther (2017) 0.75
From marrow to matrix: novel gene and cell therapies for epidermolysis bullosa. Mol Ther (2015) 0.75
Cytokine-free directed differentiation of human pluripotent stem cells efficiently produces hemogenic endothelium with lymphoid potential. Stem Cell Res Ther (2017) 0.75
Definitive Hematopoietic Multipotent Progenitor Cells Are Transiently Generated From Hemogenic Endothelial Cells in Human Pluripotent Stem Cells. J Cell Physiol (2015) 0.75
Dissecting diabetes/metabolic disease mechanisms using pluripotent stem cells and genome editing tools. Mol Metab (2015) 0.75
Stem cells in translation: impression of the ISSCR Regional Meeting in Florence. Stem Cell Reports (2013) 0.75
Generation and Analysis of GATA2(w/eGFP) Human ESCs Reveal ITGB3/CD61 as a Reliable Marker for Defining Hemogenic Endothelial Cells during Hematopoiesis. Stem Cell Reports (2016) 0.75
Direct Induction of Hemogenic Endothelium and Blood by Overexpression of Transcription Factors in Human Pluripotent Stem Cells. J Vis Exp (2015) 0.75
The mitochondrial protein CHCHD2 primes the differentiation potential of human induced pluripotent stem cells to neuroectodermal lineages. J Cell Biol (2016) 0.75
Concise Review: Recent Advances in the In Vitro Derivation of Blood Cell Populations. Stem Cells Transl Med (2016) 0.75
Using induced human pluripotent stem cells to study Diamond-Blackfan anemia: an outlook on the clinical possibilities. Expert Rev Hematol (2013) 0.75
Genetic Tagging During Human Mesoderm Differentiation Reveals Tripotent Lateral Plate Mesodermal Progenitors. Stem Cells (2016) 0.75
Isolation of Murine Embryonic Hemogenic Endothelial Cells. J Vis Exp (2016) 0.75
Emerging cellular and gene therapies for congenital anemias. Am J Med Genet C Semin Med Genet (2016) 0.75
Targeted Disruption of TCF12 Reveals HEB as Essential in Human Mesodermal Specification and Hematopoiesis. Stem Cell Reports (2017) 0.75
Induced Pluripotent Stem Cell for the Study and Treatment of Sickle Cell Anemia. Stem Cells Int (2017) 0.75
Chromatin and Transcriptional Analysis of Mesoderm Progenitor Cells Identifies HOPX as a Regulator of Primitive Hematopoiesis. Cell Rep (2017) 0.75
Targeted genome editing restores T cell differentiation in a humanized X-SCID pluripotent stem cell disease model. Sci Rep (2017) 0.75
Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell (2008) 10.34
Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro. Immunity (2002) 8.17
Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell (2011) 6.71
Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med (2007) 6.55
Development of definitive endoderm from embryonic stem cells in culture. Development (2004) 4.61
Haemangioblast commitment is initiated in the primitive streak of the mouse embryo. Nature (2004) 4.20
Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. Cardiovasc Res (2005) 3.99
Development of the hemangioblast defines the onset of hematopoiesis in human ES cell differentiation cultures. Blood (2007) 3.71
Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. Cell Stem Cell (2012) 3.66
Tracking mesoderm induction and its specification to the hemangioblast during embryonic stem cell differentiation. Development (2003) 3.60
Notch promotes survival of pre-T cells at the beta-selection checkpoint by regulating cellular metabolism. Nat Immunol (2005) 3.51
Induction of T cell development and establishment of T cell competence from embryonic stem cells differentiated in vitro. Nat Immunol (2004) 3.33
BMP-4 is required for hepatic specification of mouse embryonic stem cell-derived definitive endoderm. Nat Biotechnol (2006) 3.02
Zoned out: functional mapping of stromal signaling microenvironments in the thymus. Annu Rev Immunol (2007) 2.98
Heterogeneity among DN1 prothymocytes reveals multiple progenitors with different capacities to generate T cell and non-T cell lineages. Immunity (2004) 2.84
SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells. Nat Biotechnol (2011) 2.84
Stage-specific signaling through TGFβ family members and WNT regulates patterning and pancreatic specification of human pluripotent stem cells. Development (2011) 2.82
A temporal chromatin signature in human embryonic stem cells identifies regulators of cardiac development. Cell (2012) 2.81
Identification and targeting of the ROSA26 locus in human embryonic stem cells. Nat Biotechnol (2007) 2.75
Maintenance of T cell specification and differentiation requires recurrent notch receptor-ligand interactions. J Exp Med (2004) 2.58
Commitment and developmental potential of extrathymic and intrathymic T cell precursors: plenty to choose from. Immunity (2007) 2.51
Generation of anterior foregut endoderm from human embryonic and induced pluripotent stem cells. Nat Biotechnol (2011) 2.22
Obligatory role for cooperative signaling by pre-TCR and Notch during thymocyte differentiation. J Immunol (2004) 2.18
Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes. Nat Methods (2013) 2.14
gp96, an endoplasmic reticulum master chaperone for integrins and Toll-like receptors, selectively regulates early T and B lymphopoiesis. Blood (2009) 2.07
Wnt signaling controls the specification of definitive and primitive hematopoiesis from human pluripotent stem cells. Nat Biotechnol (2014) 2.05
Induction of T-cell development from human cord blood hematopoietic stem cells by Delta-like 1 in vitro. Blood (2004) 1.98
Delayed, asynchronous, and reversible T-lineage specification induced by Notch/Delta signaling. Genes Dev (2005) 1.98
Sequential development of hematopoietic and cardiac mesoderm during embryonic stem cell differentiation. Proc Natl Acad Sci U S A (2005) 1.85
Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantation. Nat Med (2006) 1.85
Survivin loss in thymocytes triggers p53-mediated growth arrest and p53-independent cell death. J Exp Med (2004) 1.80
HES1 opposes a PTEN-dependent check on survival, differentiation, and proliferation of TCRβ-selected mouse thymocytes. Blood (2012) 1.76
Notch activation by the metalloproteinase ADAM17 regulates myeloproliferation and atopic barrier immunity by suppressing epithelial cytokine synthesis. Immunity (2012) 1.75
Regulation of thymocyte differentiation: pre-TCR signals and beta-selection. Semin Immunol (2002) 1.75
Development and function of myeloid-derived suppressor cells generated from mouse embryonic and hematopoietic stem cells. Stem Cells (2010) 1.75
Runx1 is essential for hematopoietic commitment at the hemangioblast stage of development in vitro. Blood (2002) 1.72
Stage-specific and differential notch dependency at the alphabeta and gammadelta T lineage bifurcation. Immunity (2006) 1.70
FOXO1 is an essential regulator of pluripotency in human embryonic stem cells. Nat Cell Biol (2011) 1.70
The OP9-DL1 system: generation of T-lymphocytes from embryonic or hematopoietic stem cells in vitro. Cold Spring Harb Protoc (2009) 1.66
The thymus as an inductive site for T lymphopoiesis. Annu Rev Cell Dev Biol (2007) 1.64
Enhanced proapoptotic effects of tumor necrosis factor-related apoptosis-inducing ligand on temozolomide-resistant glioma cells. J Neurosurg (2007) 1.63
In vivo gene delivery by embryonic-stem-cell-derived astrocytes for malignant gliomas. Neuro Oncol (2008) 1.62
Leukocyte infiltration and activation of the NLRP3 inflammasome in white adipose tissue following thermal injury. Crit Care Med (2014) 1.52
Mouse embryonic stem cell-derived embryoid bodies generate progenitors that integrate long term into renal proximal tubules in vivo. J Am Soc Nephrol (2007) 1.50
Serum-free differentiation of functional human coronary-like vascular smooth muscle cells from embryonic stem cells. Cardiovasc Res (2012) 1.47
Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics. J Gen Physiol (2013) 1.44
Marked induction of the helix-loop-helix protein Id3 promotes the gammadelta T cell fate and renders their functional maturation Notch independent. Immunity (2009) 1.43
Differential long-term and multilineage engraftment potential from subfractions of human CD34+ cord blood cells transplanted into NOD/SCID mice. Proc Natl Acad Sci U S A (2002) 1.41
Hypoxia affects mesoderm and enhances hemangioblast specification during early development. Development (2004) 1.41
Developmental regulation of yolk sac hematopoiesis by Kruppel-like factor 6. Blood (2005) 1.39
Mechanism-based facilitated maturation of human pluripotent stem cell-derived cardiomyocytes. Circ Arrhythm Electrophysiol (2013) 1.38
Direct comparison of Dll1- and Dll4-mediated Notch activation levels shows differential lymphomyeloid lineage commitment outcomes. J Immunol (2010) 1.37
SCL/Tal-1 is essential for hematopoietic commitment of the hemangioblast but not for its development. Blood (2005) 1.37
Alternative induced pluripotent stem cell characterization criteria for in vitro applications. Cell Stem Cell (2009) 1.36
Directed differentiation of mouse embryonic stem cells into thyroid follicular cells. Endocrinology (2006) 1.35
Distinct roles of microRNA-1 and -499 in ventricular specification and functional maturation of human embryonic stem cell-derived cardiomyocytes. PLoS One (2011) 1.34
Human adenylate kinase 2 deficiency causes a profound hematopoietic defect associated with sensorineural deafness. Nat Genet (2008) 1.31
Differential synergy of Notch and T cell receptor signaling determines alphabeta versus gammadelta lineage fate. J Exp Med (2006) 1.29
Notch signaling requires GATA-2 to inhibit myelopoiesis from embryonic stem cells and primary hemopoietic progenitors. J Immunol (2006) 1.29
The expression of Sox17 identifies and regulates haemogenic endothelium. Nat Cell Biol (2013) 1.28
Beyond tumor necrosis factor receptor: TRADD signaling in toll-like receptors. Proc Natl Acad Sci U S A (2008) 1.26
Retinoic acid signaling is essential for embryonic hematopoietic stem cell development. Cell (2013) 1.25
Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors. Nat Biotechnol (2008) 1.24
A survival guide to early T cell development. Immunol Res (2006) 1.24
Committing embryonic stem cells to early endocrine pancreas in vitro. Stem Cells (2004) 1.23
Three-dimensional culture and cAMP signaling promote the maturation of human pluripotent stem cell-derived hepatocytes. Development (2013) 1.23
Characterization in vitro and engraftment potential in vivo of human progenitor T cells generated from hematopoietic stem cells. Blood (2009) 1.22
The basic helix-loop-helix transcription factor HEBAlt is expressed in pro-T cells and enhances the generation of T cell precursors. J Immunol (2006) 1.21
The homeobox gene HEX regulates proliferation and differentiation of hemangioblasts and endothelial cells during ES cell differentiation. Blood (2005) 1.21
Notch signaling respecifies the hemangioblast to a cardiac fate. Nat Biotechnol (2008) 1.19
T-cell development, doing it in a dish. Immunol Rev (2006) 1.18
Three-dimensional architecture of the thymus is required to maintain delta-like expression necessary for inducing T cell development. J Immunol (2006) 1.17
Chromosome transfer activates and delineates a locus control region for perforin. Immunity (2007) 1.16
Propensity of adult lymphoid progenitors to progress to DN2/3 stage thymocytes with Notch receptor ligation. J Immunol (2005) 1.15
Serial in vivo positive contrast MRI of iron oxide-labeled embryonic stem cell-derived cardiac precursor cells in a mouse model of myocardial infarction. Magn Reson Med (2008) 1.14
Generation of beta cells from human pluripotent stem cells: Potential for regenerative medicine. Semin Cell Dev Biol (2012) 1.12
In vitro generation of T lymphocytes from embryonic stem cell-derived prehematopoietic progenitors. Blood (2003) 1.12
Parthenogenetic stem cells for tissue-engineered heart repair. J Clin Invest (2013) 1.11
Defining the path to hematopoietic stem cells. Nat Biotechnol (2013) 1.11
Determining γδ versus αß T cell development. Nat Rev Immunol (2010) 1.09
Biophysical properties of slow potassium channels in human embryonic stem cell derived cardiomyocytes implicate subunit stoichiometry. J Physiol (2011) 1.08
T-cell potential and development in vitro: the OP9-DL1 approach. Curr Opin Immunol (2007) 1.08
Differences in lymphocyte developmental potential between human embryonic stem cell and umbilical cord blood-derived hematopoietic progenitor cells. Blood (2008) 1.08
Smad1 expands the hemangioblast population within a limited developmental window. Blood (2006) 1.05
Low activation threshold as a mechanism for ligand-independent signaling in pre-T cells. J Immunol (2003) 1.02
Tracking mesoderm formation and specification to the hemangioblast in vitro. Trends Cardiovasc Med (2004) 1.00
In vitro systems for the study of T cell development: fetal thymus organ culture and OP9-DL1 cell coculture. Curr Protoc Immunol (2006) 0.99
High transduction efficiency of human amniotic fluid stem cells mediated by adenovirus vectors. Stem Cells Dev (2008) 0.97
TGF-β affects development and differentiation of human natural killer cell subsets. Eur J Immunol (2010) 0.97
Mouse Mix gene is activated early during differentiation of ES and F9 stem cells and induces endoderm in frog embryos. Dev Dyn (2003) 0.97
Micro-arrayed human embryonic stem cells-derived cardiomyocytes for in vitro functional assay. PLoS One (2012) 0.96
An overview of the intrathymic intricacies of T cell development. J Immunol (2014) 0.96
T-cell generation by lymph node resident progenitor cells. Blood (2005) 0.95
Haploinsufficiency of Runx1 results in the acceleration of mesodermal development and hemangioblast specification upon in vitro differentiation of ES cells. Blood (2003) 0.94
Constitutive Notch signalling promotes CD4 CD8 thymocyte differentiation in the absence of the pre-TCR complex, by mimicking pre-TCR signals. Int Immunol (2007) 0.94
Human proT-cells generated in vitro facilitate hematopoietic stem cell-derived T-lymphopoiesis in vivo and restore thymic architecture. Blood (2013) 0.94
The homeobox gene Hex regulates hepatocyte differentiation from embryonic stem cell-derived endoderm. Hepatology (2010) 0.94